| 17856-2170-1 |
17856-2170 |
HUMAN PRESCRIPTION DRUG |
Acyclovir suspension |
Acyclovir |
SUSPENSION |
ORAL |
20260504 |
N/A |
ANDA |
ANDA217393 |
Atlantic Biologicals Corp. |
ACYCLOVIR |
200 mg/5mL |
72 CUP, UNIT-DOSE in 1 CASE (17856-2170-1) / 5 mL in 1 CUP, UNIT-DOSE |
| 17856-2170-2 |
17856-2170 |
HUMAN PRESCRIPTION DRUG |
Acyclovir suspension |
Acyclovir |
SUSPENSION |
ORAL |
20260504 |
N/A |
ANDA |
ANDA217393 |
Atlantic Biologicals Corp. |
ACYCLOVIR |
200 mg/5mL |
72 CUP, UNIT-DOSE in 1 CASE (17856-2170-2) / 10 mL in 1 CUP, UNIT-DOSE |
| 72205-170-72 |
72205-170 |
HUMAN PRESCRIPTION DRUG |
Acyclovir suspension |
Acyclovir |
SUSPENSION |
ORAL |
20231023 |
N/A |
ANDA |
ANDA217393 |
Novadoz Pharmaceuticals LLC |
ACYCLOVIR |
200 mg/5mL |
473 mL in 1 BOTTLE (72205-170-72) |